PART I . Overview DBV Technologies is a late-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. Our therapeutic approach is based on epicutaneous immunotherapy, or EPIT, our proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). We have generated significant data demonstrating that Viaskin patch...
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-26 | 2025-12-31 | 0001628280-26-021504 | EDGAR | 99K words |
| 2025-04-11 | 2024-12-31 | 0001613780-25-000006 | EDGAR | — |
| 2024-03-07 | 2023-12-31 | 0001193125-24-062357 | EDGAR | — |
| 2023-03-02 | 2022-12-31 | 0001193125-23-058309 | EDGAR | — |
| 2022-03-09 | 2021-12-31 | 0001193125-22-070467 | EDGAR | — |
| 2021-03-17 | 2020-12-31 | 0001193125-21-084223 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-10-28 | 2025-09-30 | 0001628280-25-046809 | EDGAR | 22K words |
| 2025-07-29 | 2025-06-30 | 0001613780-25-000016 | EDGAR | — |
| 2025-04-30 | 2025-03-31 | 0001613780-25-000011 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0001613780-24-000007 | EDGAR | — |
| 2024-07-30 | 2024-06-30 | 0001193125-24-188853 | EDGAR | — |
| 2024-05-07 | 2024-03-31 | 0001193125-24-133228 | EDGAR | — |
| 2023-10-31 | 2023-09-30 | 0001193125-23-267271 | EDGAR | — |
| 2023-07-31 | 2023-06-30 | 0001193125-23-199175 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0001193125-23-136030 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0001193125-22-277052 | EDGAR | — |
| 2022-08-01 | 2022-06-30 | 0001193125-22-208808 | EDGAR | — |
| 2022-05-02 | 2022-03-31 | 0001193125-22-136833 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-26 | 0001193125-26-126671 | EDGAR | 2K words |
| 2026-03-02 | 0001193125-26-084251 | EDGAR | — |
| 2026-01-20 | 0001193125-26-015592 | EDGAR | — |
| 2025-12-16 | 0001193125-25-320901 | EDGAR | — |
| 2025-10-30 | 0001193125-25-258780 | EDGAR | — |
| 2025-10-29 | 0001193125-25-253968 | EDGAR | — |
| 2025-09-18 | 0001193125-25-207507 | EDGAR | — |
| 2025-09-05 | 0001193125-25-197277 | EDGAR | — |
| 2025-07-29 | 0001193125-25-168148 | EDGAR | — |
| 2025-06-25 | 0001193125-25-146994 | EDGAR | — |
316 total filings indexed. 288 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001613780 |
| Ticker | DBVT |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | I0 |
| Website | https://www.dbv-technologies.com |
| Listed | 2014-10-22 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report